Year |
Citation |
Score |
2009 |
Wildeboer KM, Zheng L, Choo KS, Stevens KE. Ondansetron results in improved auditory gating in DBA/2 mice through a cholinergic mechanism. Brain Research. 1300: 41-50. PMID 19728991 DOI: 10.1016/j.brainres.2009.08.075 |
0.373 |
|
2008 |
Wildeboer KM, Stevens KE. Stimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice. Brain Research. 1224: 29-36. PMID 18582447 DOI: 10.1016/j.brainres.2008.06.007 |
0.371 |
|
2006 |
Lee ST, Wildeboer K, Panter KE, Kem WR, Gardner DR, Molyneux RJ, Chang CW, Soti F, Pfister JA. Relative toxicities and neuromuscular nicotinic receptor agonistic potencies of anabasine enantiomers and anabaseine. Neurotoxicology and Teratology. 28: 220-8. PMID 16488116 DOI: 10.1016/J.Ntt.2005.12.010 |
0.464 |
|
2006 |
Kem W, Soti F, Wildeboer K, LeFrancois S, MacDougall K, Wei DQ, Chou KC, Arias HR. The nemertine toxin anabaseine and its derivative DMXBA (GTS-21): Chemical and pharmacological properties Marine Drugs. 4: 255-273. DOI: 10.3390/Md403255 |
0.391 |
|
2004 |
Kem WR, Wildeboer K, LeFrancois S, Raja M, Marszalec W, Braekman JC. Nicotinic receptor inhibition by Tetraponera ant alkaloids. Cellular and Molecular Neurobiology. 24: 535-51. PMID 15233377 DOI: 10.1023/B:Cemn.0000023628.65936.A7 |
0.479 |
|
2004 |
Kem WR, Mahnir VM, Prokai L, Papke RL, Cao X, LeFrancois S, Wildeboer K, Prokai-Tatrai K, Porter-Papke J, Soti F. Hydroxy metabolites of the Alzheimer's drug candidate 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride (GTS-21): their molecular properties, interactions with brain nicotinic receptors, and brain penetration. Molecular Pharmacology. 65: 56-67. PMID 14722237 DOI: 10.1124/Mol.65.1.56 |
0.492 |
|
Show low-probability matches. |